| Name | Title | Contact Details |
|---|
DAST Consulting Services is a rapidly growing company that is part of a consortium of organizations with a vision to unlock financial resources so that every kid in America has access to a Christ-centered education. We collaborate with accredited non-public schools to help them leverage various revenue streams, including federal and state grant funding programs as well as innovative work-based learning initiatives. DAST also has an active venture studio (DAST Investments) with multiple portfolio companies, and a nonprofit (DAST Foundation) that recently launched a Classical Christian Microschool network.
Built from the ground up to support computationally intensive workloads, we provide the best tools for creators leveraging powerful accelerated hardware. A traditionally costly and scarce resource, GPU compute options from mono-lithic cloud providers are extremely limited. CoreWeave provides the industry`s widest range of GPU options, allowing you to pick the perfect GPU for your use case. Thousands of GPUs are ready and waiting.
Atosa is a major manufacturer of commercial kitchen equipment, with a breadth of offering including refrigeration, cooking equipment, warming/holding equipment, stainless steel fabrication equipment, and much more. Atosas world-class manufacturing facilities and highly skilled employees, combined with innovative manufacturing procedures ensure that our customers always receive top-quality products at economical prices.
Assured Legacy is a health and life insurance agency that is partnered with multiple Insurance Companies to help clients find plans and policies that best fit their needs. Our Licensed Insurance Benefits Advisors guide clients through the process of assessing and understanding which benefit plans best align with their future needs and financial goals. Please visit assuredlegacy.net to learn more and schedule a no-obligation - complimentary consultation with a Licensed Insurance Benefits Advisor.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.